FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys for patients with end-stage renal disease. Study aims to provide alternative for 500,000 Americans on dialysis.

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for more than two years.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first recipient of a gene-edited pig kidney died from cardiac causes within 2 months, but there was no evidence of xenograft rejection, a brief report detailed.

A 66-year-old man, Tim Andrews, has successfully undergone a pig kidney transplant, becoming the second person to do so.

A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time successfully transplanted a genetically edited pig kidney into a living person. The team performed the first surgery of its kind in the world in March 2024.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.

A Concord man is the latest recipient of an unusual procedure: He's had his kidney replaced with one from a pig.

A Mass General Hospital surgical team has completed its second pig-to-human kidney transplant, less than a year after the hospital performed the world’s first such surgery.